47 related articles for article (PubMed ID: 12452038)
1. [Activation of phosphatidylinositol 3-kinase in human breast carcinoma].
Zhang Y; Song M; Mi XY; Wang H; Song JY
Ai Zheng; 2002 May; 21(5):489-92. PubMed ID: 12452038
[TBL] [Abstract][Full Text] [Related]
2. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
[TBL] [Abstract][Full Text] [Related]
3. Phosphatidylinositol 3-kinase/AKT pathway activation in human vestibular schwannoma.
Jacob A; Lee TX; Neff BA; Miller S; Welling B; Chang LS
Otol Neurotol; 2008 Jan; 29(1):58-68. PubMed ID: 18199958
[TBL] [Abstract][Full Text] [Related]
4. Human telomerase reverse transcriptase mRNA is highly expressed in normal breast tissues and down-regulated in ductal carcinoma in situ.
Liu J; Baykal A; Fung KM; Thompson-Lanza JA; Hoque A; Lippman SM; Sahin A
Int J Oncol; 2004 Apr; 24(4):879-84. PubMed ID: 15010825
[TBL] [Abstract][Full Text] [Related]
5. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
de Candia P; Akram M; Benezra R; Brogi E
Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
[TBL] [Abstract][Full Text] [Related]
6. [Quantitative detection of telomerase activity and its association with clinicopathological characteristics in breast cancer].
He GP; Shui QL; Huang Y; Zhang SZ; Yu H
Ai Zheng; 2004 Sep; 23(9):1041-6. PubMed ID: 15363198
[TBL] [Abstract][Full Text] [Related]
7. The status of cyclooxygenase-2 expression in ductal carcinoma in situ lesions and invasive breast cancer correlates to cyclooxygenase-2 expression in normal breast tissue.
Leo C; Faber S; Hentschel B; Höckel M; Horn LC
Ann Diagn Pathol; 2006 Dec; 10(6):327-32. PubMed ID: 17126249
[TBL] [Abstract][Full Text] [Related]
8. PIK3CA gene mutations in breast carcinoma in Malaysian patients.
Ching-Shian Leong V; Jabal MF; Leong PP; Abdullah MA; Gul YA; Seow HF
Cancer Genet Cytogenet; 2008 Dec; 187(2):74-9. PubMed ID: 19027487
[TBL] [Abstract][Full Text] [Related]
9. Down regulation of the expression of the p110, p85 and p55 subunits of phosphatidylinositol 3-kinase during colon cancer cell anchorage-independent growth.
Yeates LC; Gallegos A; Kozikowski AP; Powis G
Anticancer Res; 1999; 19(5B):4171-6. PubMed ID: 10628371
[TBL] [Abstract][Full Text] [Related]
10. Increased dihydropyrimidine dehydrogenase activity in breast cancer.
Anan K; Mitsuyama S; Tamae K; Suehara N; Nishihara K; Ogawa Y; Abe Y; Iwashita T; Toyoshima S
J Surg Oncol; 2003 Mar; 82(3):174-9. PubMed ID: 12619061
[TBL] [Abstract][Full Text] [Related]
11. Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma.
Madan R; Smolkin MB; Cocker R; Fayyad R; Oktay MH
Hum Pathol; 2006 Jan; 37(1):9-15. PubMed ID: 16360410
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiles of the fibroblasts from breast tumors and normal tissue compared with the tumor expression profiles.
Hussain SS; Qattan AT; Nirmal MS; Al-Malik OA; Al-Tweigeri TA; Tulba AM; Bin Amer SM
Saudi Med J; 2006 Apr; 27(4):463-9. PubMed ID: 16598321
[TBL] [Abstract][Full Text] [Related]
13. Differential responses to doxorubicin-induced phosphorylation and activation of Akt in human breast cancer cells.
Li X; Lu Y; Liang K; Liu B; Fan Z
Breast Cancer Res; 2005; 7(5):R589-97. PubMed ID: 16168102
[TBL] [Abstract][Full Text] [Related]
14. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal peptide (VIP) increases vascular endothelial growth factor (VEGF) expression and secretion in human breast cancer cells.
Valdehita A; Carmena MJ; Collado B; Prieto JC; Bajo AM
Regul Pept; 2007 Dec; 144(1-3):101-8. PubMed ID: 17683807
[TBL] [Abstract][Full Text] [Related]
16. The involvement of phosphatidylinositol 3-kinase in gonadotropin-releasing hormone-induced gonadotropin alpha- and FSHbeta-subunit genes expression in clonal gonadotroph LbetaT2 cells.
Mutiara S; Kanasaki H; Harada T; Oride A; Miyazaki K
Mol Cell Endocrinol; 2008 Feb; 283(1-2):1-11. PubMed ID: 18206295
[TBL] [Abstract][Full Text] [Related]
17. IGF-1 activates hEAG K(+) channels through an Akt-dependent signaling pathway in breast cancer cells: role in cell proliferation.
Borowiec AS; Hague F; Harir N; Guénin S; Guerineau F; Gouilleux F; Roudbaraki M; Lassoued K; Ouadid-Ahidouch H
J Cell Physiol; 2007 Sep; 212(3):690-701. PubMed ID: 17520698
[TBL] [Abstract][Full Text] [Related]
18. Phospholipid hydroperoxide glutathione peroxidase (PHGPx) expression is downregulated in poorly differentiated breast invasive ductal carcinoma.
Cejas P; García-Cabezas MA; Casado E; Belda-Iniesta C; De Castro J; Fresno JA; Sereno M; Barriuso J; Espinosa E; Zamora P; Feliu J; Redondo A; Hardisson DA; Renart J; González-Barón M
Free Radic Res; 2007 Jun; 41(6):681-7. PubMed ID: 17516241
[TBL] [Abstract][Full Text] [Related]
19. KIT oncogenic signaling mechanisms in imatinib-resistant gastrointestinal stromal tumor: PI3-kinase/AKT is a crucial survival pathway.
Bauer S; Duensing A; Demetri GD; Fletcher JA
Oncogene; 2007 Nov; 26(54):7560-8. PubMed ID: 17546049
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome.
Vestey SB; Perks CM; Sen C; Calder CJ; Holly JM; Winters ZE
Breast Cancer Res; 2005; 7(1):R119-29. PubMed ID: 15642160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]